Advertisement
Screener

CAPRICOR THERAPEUTICS, INC. (CAPR) ROA

CAPRICOR THERAPEUTICS, INC. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • CAPRICOR THERAPEUTICS, INC. roa for the quarter ending 2026-06-30 was -35.10%, a change of 17.29% year-over-year.
  • CAPRICOR THERAPEUTICS, INC. roa for the quarter ending 2026-03-31 was -35.12%, a change of 0.69% year-over-year.
  • CAPRICOR THERAPEUTICS, INC. roa for the quarter ending 2025-12-31 was -29.51%, a change of -5.77% year-over-year.
  • CAPRICOR THERAPEUTICS, INC. roa for the quarter ending 2025-09-30 was -64.85%, a change of -28.15% year-over-year.
  • CAPRICOR THERAPEUTICS, INC. roa for fiscal 2025 was -29.51%, a change of -5.77% from fiscal 2024.
  • CAPRICOR THERAPEUTICS, INC. roa for fiscal 2024 was -23.74%, a change of 14.21% from fiscal 2023.
  • CAPRICOR THERAPEUTICS, INC. roa for fiscal 2023 was -37.95%, a change of 19.98% from fiscal 2022.
  • CAPRICOR THERAPEUTICS, INC. roa for fiscal 2022 was -57.93%, a change of -9.48% from fiscal 2021.
Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-30-35.10%-$129.42M-$40.73M$368.74M
2026-03-31-35.12%-$114.59M-$33.94M$326.28M
2025-12-31-29.51%-$105.04M-$30.17M$355.95M
2025-09-30-64.85%-$81.99M-$24.57M$126.44M
2025-06-30-52.39%-$69.98M-$25.91M$133.57M
2025-03-31-35.81%-$55.06M-$24.39M$153.77M
2024-12-31-23.74%-$40.47M-$7.12M$170.48M
2024-09-30-36.70%-$34.11M-$12.56M$92.95M
2024-06-30-73.01%-$27.95M-$11.00M$38.28M
2024-03-31-49.17%-$24.31M-$9.79M$49.44M
2023-12-31-37.95%-$22.29M-$762.09K$58.73M
2023-09-30-78.72%-$29.25M-$6.39M$37.15M
2023-06-30-63.52%-$29.23M-$7.37M$46.01M
2023-03-31-53.78%-$28.97M-$7.77M$53.86M
2022-12-31-57.93%-$29.02M-$7.72M$50.09M
2022-09-30-50.97%-$27.49M-$6.37M$53.93M
2022-06-30-43.14%-$25.05M-$7.11M$58.07M
2022-03-31-34.95%-$22.69M-$7.82M$64.92M
2021-12-31-48.45%-$20.02M-$6.19M$41.33M
2021-09-30-41.79%-$18.01M-$3.93M$43.1M
2021-06-30-45.05%-$17.99M-$4.75M$39.93M
2021-03-31-38.41%-$16.72M-$5.15M$43.54M
2020-12-31-39.45%-$13.66M-$4.18M$34.62M
2020-09-30-30.26%-$10.95M-$3.91M$36.19M
2020-06-30-23.29%-$8.64M-$3.48M$37.13M
2020-03-31-50.42%-$7.21M-$2.08M$14.29M
2019-12-31-68.76%-$7.64M-$1.47M$11.11M
2019-09-30-119.28%-$9.43M-$1.61M$7.91M
2019-06-30-163.71%-$11.96M-$2.05M$7.31M
2019-03-31-162.91%-$14.04M-$2.52M$8.62M
2018-12-31-164.28%-$15.19M-$3.26M$9.25M
2018-09-303.06%$373,955.00-$4.14M$12.23M
2018-06-3012.39%$1.78M-$4.12M$14.33M
2018-03-3115.77%$2.43M-$3.67M$15.39M
2017-12-3114.94%$2.43M$12.31M$16.27M
2017-09-30-91.13%-$14.39M-$2.73M$15.79M
2017-06-30-119.50%-$16.99M-$3.47M$14.22M
2017-03-31-129.42%-$18.21M-$3.67M$14.07M
2016-12-31-100.32%-$18.81M-$4.52M$18.75M
2016-09-30-72.06%-$17.63M-$5.33M$24.47M
2016-06-30-109.51%-$15.21M-$4.69M$13.89M
2016-03-31-80.35%-$13.65M-$4.27M$16.98M
2015-12-31-80.01%-$12.86M-$3.35M$16.07M
2015-09-30-57.53%-$11.44M-$2.91M$19.88M
2015-06-30-42.51%-$10.07M-$3.12M$23.69M
2015-03-31-30.88%-$8.48M-$3.48M$27.47M
2014-12-31-45.60%-$6.22M-$1.93M$13.63M
2014-09-30-52.78%-$8.59M-$1.54M$16.28M
2014-06-30-46.62%-$8.59M-$1.53M$18.44M
2014-03-31-54.36%-$8.69M-$1.21M$15.98M
2013-12-31-160.56%-$8.89M-$4.30M$5.54M
2013-09-30-4343.21%-$4.97M-$1.55M$114,366.00
2013-06-30-1352.73%-$3.99M-$1.62M$294,822.00
2013-03-31-654.09%-$2.72M-$1.42M$415,308.00
2012-12-31-38.19%-$2.07M-$201.99K$5.42M
2012-09-3076.74%$380,031.00-$566.23K$495,225.00
2012-06-30-19.78%-$197,810.00-$352.93K$1M
2012-03-31-101.31%-$725,406.00-$771.88K$716,006.00
2011-12-31-83.76%-$1.15M-$1.66M$1.37M
2011-09-3031.05%$959,691.00-$1.14M$3.09M
2011-06-307.94%$294,271.00-$880.53K$3.7M

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-31-29.51%-$105.04M$355.95M
2024-12-31-23.74%-$40.47M$170.48M
2023-12-31-37.95%-$22.29M$58.73M
2022-12-31-57.93%-$29.02M$50.09M
2021-12-31-48.45%-$20.02M$41.33M
2020-12-31-39.45%-$13.66M$34.62M
2019-12-31-68.76%-$7.64M$11.11M
2018-12-31-164.28%-$15.19M$9.25M
2017-12-3114.94%$2.43M$16.27M
2016-12-31-100.32%-$18.81M$18.75M
2015-12-31-80.01%-$12.86M$16.07M
2014-12-31-45.60%-$6.22M$13.63M
2013-12-31-160.56%-$8.89M$5.54M
2012-12-31-38.19%-$2.07M$5.42M
2011-12-31-83.76%-$1.15M$1.37M
2010-12-31-28.80%-$1.06M$3.67M

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63